Shares of Hims & Hers Health (HIMS) tumbled 15% yesterday after Novo Nordisk (NVO) announced it was cutting the price of its GLP-1 weight-loss...
Hims & Hers (NYSE:HIMS) has delivered blockbuster performance over the past month and was on its way to delivering over 200% returns. The surge...
Shares of direct-to-consumer healthcare platform Hims & Hers (HIMS) raced 60% higher over the past week after a successful Super Bowl ad, despite...
Hims & Hers Health (NYSE:HIMS) is surging today. The stock is up 19%, and this is part of a broader 482.5% rally in the past year that has...
Shares of healthcare company Hims & Hers (HIMS) led the market higher on Friday with gains of almost 8%. The move completes a 50% rally over...
